Sarah Ketterer's NVO Position Overview
Sarah Ketterer (via Causeway Capital Management LLC) currently holds 696.0K shares of Novo Nordisk A/S (NVO) worth $38.62 M, representing 0.51% of the portfolio. First purchased in 2025-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Sarah Ketterer has initiated a new position in NVO, representing a fresh investment thesis on this company. Largest addition occurred in Q3 2025, adding 342.1K shares.
Analysis based on 13F filings available since 2013 Q2
Sarah Ketterer's Novo Nordisk A/S (NVO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novo Nordisk A/S (NVO) Trades by Sarah Ketterer
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +353,884 | New Buy | 353,884 | $69.02 |
| Q3 2025 | +342,095 | Add 96.67% | 695,979 | $55.49 |
Sarah Ketterer's Novo Nordisk A/S Investment FAQs
Sarah Ketterer first purchased Novo Nordisk A/S (NVO) in Q2 2025, acquiring 353,884 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Sarah Ketterer has held Novo Nordisk A/S (NVO) for 2 quarters since Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Sarah Ketterer's largest addition to Novo Nordisk A/S (NVO) was in Q2 2025, adding 353,884 shares worth $24.43 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Sarah Ketterer's firm, Causeway Capital Management LLC, owns 695,979 shares of Novo Nordisk A/S (NVO), valued at approximately $38.62 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Novo Nordisk A/S (NVO) represents approximately 0.51% of Sarah Ketterer's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Sarah Ketterer's peak holding in Novo Nordisk A/S (NVO) was 695,979 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.